IgA nephropathy: Difference between revisions
No edit summary |
|||
Line 45: | Line 45: | ||
== Treatment == | == Treatment == | ||
[[IgA nephropathy medical therapy|Medical Therapy]] | [[IgA nephropathy surgery|Surgery]] | [[IgA nephropathy primary prevention|Primary Prevention]] | [[IgA nephropathy secondary prevention|Secondary | [[IgA nephropathy medical therapy|Medical Therapy]] | [[IgA nephropathy surgery|Surgery]] | [[IgA nephropathy primary prevention|Primary Prevention]] | [[IgA nephropathy secondary prevention|Secondary Prevention]] | [[IgA nephropathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[IgA nephropathy future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 22:37, 27 September 2012
For patient information click here Template:DiseaseDisorder infobox
IgA nephropathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
IgA nephropathy On the Web |
American Roentgen Ray Society Images of IgA nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating IgA nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies